Pfizer’s COVID-19 vaccine trial data shows long-term efficacy in adolescents
Pfizer Inc said on Monday its COVID-19 vaccine provided strong long-term protection against the virus in a late-stage study conducted among adolescents aged 12 to 15 years. A two-dose series of…
